Maria Thacker-Goethe, Georgia Bio President and CEO, Named to “100 Most Influential Georgians” list by Georgia Trend Magazine

Atlanta, Georgia (January 11, 2021) – Georgia Bio, the state’s public policy and business solutions organization representing Georgia’s life sciences sector, announced today that President and CEO Maria Thacker-Goethe was named to Georgia Trend magazine’s “100 Most Influential Georgians” list for 2021.

“It is an incredible honor to be chosen amongst such esteemed colleagues,” said Maria Thacker-Goethe, Georgia Bio’s president and CEO. “The list contains several of our life sciences partners, exhibiting the influence and impact that our sector has on the state of Georgia. Thank you to Georgia Trend for the merit and for highlighting the importance of the life sciences to our state.”

In its 23 rd year, this year’s “100 Most Influential Georgians” list contains CEOs, politicians, college presidents, nonprofit and economic development leaders who “have risen to the challenges of the past year to help make life better for all Georgians.”

Per Georgia Trend : “Under Thacker-Goethe’s leadership, Georgia Bio cultivates a high-growth life sciences

sector vital by many measures, including the nearly 200,000 jobs and approximately $22-billion impact for Georgia. She not only brings 13-plus years of nonprofit management to the role, but also the vision and experience from her concurrent leadership roles at the Georgia BioEd Institute and Global Health Alliance.”

To read more and view the full list of recipients, click HERE.

Thacker-Goethe also serves as CEO for the Center for Global Health Innovation. Georgia Bio is a division of The Center for Global Health Innovation, an Atlanta based 501(c)3 organization that was launched in 2020 to bring together diverse Global Health, Health Technology and Life Sciences entities to collaborate, innovate and activate solutions to enhance human health outcomes around the world. ( innovateglobalhealth.org )

About Georgia Bio

Georgia Bio ( www.gabio.org ) is the state’s private, non-profit life sciences association. Members include pharmaceutical, biotechnology and medical device companies, medical centers, universities and research institutes, government groups and other business organizations involved in the development of life sciences related products and services.

Georgia Life Sciences Joins National Coalition Urging Congressional Action on Key Innovation Policies

December 10, 2025
Georgia Life Sciences has joined 43 state and regional life sciences organizations in signing a national Council of State Bioscience Associations (CSBA) letter calling on Congress to take immediate action on three bipartisan policy priorities that are essential to sustaining U.S. leadership in biomedical innovation and supporting patients nationwide. With Congress back in session and several critical programs at risk of expiring, the letter urges congressional leaders to advance the following provisions without delay: 1. Reauthorize the Rare Pediatric Disease Priority Review Voucher (PPRV) Program The PPRV program has been instrumental in incentivizing the development of therapies for children with rare and life-threatening conditions. Its lapse threatens to slow or halt research that families across the country are counting on. 2. Extend the SBIR/STTR Programs The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs provide crucial early-stage capital for emerging biotech and medtech companies—many of them in Georgia. Without reauthorization, hundreds of innovative small businesses face uncertainty, jeopardizing new therapies, diagnostics, and technologies in the pipeline, 3. Advance PBM Transparency Reforms Greater transparency and accountability within pharmacy benefit manager (PBM) practices are needed to ensure that savings reach patients and employers. Reforming PBM operations is essential to strengthening access and affordability across the healthcare system. A Unified Message from the Life Sciences Community The sign-on letter reflects broad, bipartisan alignment across the national life sciences ecosystem: researchers, entrepreneurs, investors, patient advocates, and state associations all share a common message— these programs underpin America’s global competitiveness and are vital to patients who rely on continued scientific progress. Georgia Life Sciences has shared the letter with members of Georgia’s congressional delegation and will continue engaging with policymakers to emphasize the importance of swift action.

GLS Joins Georgia Partners in Calling for Federal PBM Reform

December 7, 2025
Georgia Life Sciences is proud to stand with patient advocates, providers, and employers across the state in urging Congress to take meaningful action on pharmacy benefit manager (PBM) reform. We recently signed on to a joint letter to Georgia’s Congressional Delegation stressing the urgent need for transparency, fair practices, and policies that ensure savings flow directly to patients.

GLS’ President and CEO, Maria Thacker Goethe in December's issue of Georgia Trend

December 4, 2025
Georgia Life Sciences’ CEO, Maria Thacker Goethe shares her perspective on the value of Georgia’s research universities in this month’s issue of Georgia Trend. “Georgia research institutions have felt a very significant impact from the federal rollbacks, specifically in NIH and NSF funding. Thacker Goethe’s message about the impact of research cuts is simple: Disruption shatters the foundational trust researchers have in grant continuity….” To read the full article, click here .
MORE POSTS